Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
Saved in:
| Title: | Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study. |
|---|---|
| Authors: | Elez, Elena1 (AUTHOR) meelez@vhio.net, Cubillo, Antonio2,3 (AUTHOR), Alfonso, Pilar Garcia4 (AUTHOR), Middleton, Mark R.5 (AUTHOR), Chau, Ian6 (AUTHOR), Alkuzweny, Baha7 (AUTHOR), Alcasid, Ann8 (AUTHOR), Zhang, Xiaosong9 (AUTHOR), Van Cutsem, Eric10 (AUTHOR) |
| Source: | BMC Cancer. 4/11/2024, Vol. 24 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-12153-5 |
